Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 11, 2017
Patent Application Number
15134583
Date Filed
April 21, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to crystal modifications of N-{(2R)-2-[({[3,3-dibutyl-7-(methyl-thio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl]oxy}acetyl)amino]-2-phenylethanolyl}glycine (elobixibat), more specifically crystal modifications I, IV, MeOH-1, EtOH-1, 1-PrOH-1 and 2-PrOH-1. The invention also relates to a process for the preparation of these crystal modifications and to a pharmaceutical composition comprising crystal modification IV.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
